IO Biotech, Inc. — Investor Relations & Filings
IO Biotech, Inc. is a clinical-stage biopharmaceutical company developing novel, immune-modulatory therapeutic cancer vaccines. The company's proprietary T-win technology platform is engineered to create dual-action vaccines that activate the patient's T cells to simultaneously target and eliminate both cancer cells and immune-suppressive cells within the tumor microenvironment. These off-the-shelf therapies are intended to improve outcomes for patients with various solid tumors. The lead product candidate, Cylembio® (IO102-IO103), is being evaluated in clinical trials for melanoma and other cancers, while additional pipeline candidates are in preclinical development.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - IO Biotech, Inc. (0001865494) (Filer) | 2026-03-31 | English | |
| 8-K Filing | 2026-02-13 | English | |
| SCHEDULE 13G/A Filing | 2026-02-13 | English | |
| SCHEDULE 13G Filing | 2026-02-06 | English | |
| 8-K Filing | 2026-01-30 | English | |
| Major Shareholding Notification 2026 | 2026-01-23 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 33114886 | 8-K - IO Biotech, Inc. (0001865494) (Filer) | 2026-03-31 | English | ||
| 32118566 | 8-K Filing | 2026-02-13 | English | ||
| 32118523 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 32118548 | SCHEDULE 13G Filing | 2026-02-06 | English | ||
| 32118544 | 8-K Filing | 2026-01-30 | English | ||
| 13468661 | Major Shareholding Notification 2026 | 2026-01-23 | English | ||
| 13468663 | 8-K | 2026-01-21 | English | ||
|
2025
8 filings
| |||||
| 13468665 | 8-K | 2025-12-19 | English | ||
| 13468666 | 8-K | 2025-11-21 | English | ||
| 13468669 | 8-K | 2025-11-18 | English | ||
| 13468670 | Major Shareholding Notification 2025 | 2025-11-15 | English | ||
| 13468675 | 10-Q | 2025-11-14 | English | ||
| 13468676 | 8-K | 2025-11-14 | English | ||
| 13468677 | Major Shareholding Notification 2025 | 2025-11-05 | English | ||
| 13468679 | 8-K | 2025-09-29 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adlai Nortye Ltd.
A clinical-stage biopharma firm developing cancer immunothe…
|
ANL | KY | Manufacturing |
|
ADLINE CHEM LAB LIMITED
Produces APIs, chemical intermediates, and specialty chemic…
|
524604 | IN | Manufacturing |
|
ADMA BIOLOGICS, INC.
Biopharmaceutical company that develops and manufactures pl…
|
ADMA | US | Manufacturing |
|
Advectus Life Sciences Inc.
Advances drug delivery systems using proprietary nanopartic…
|
AVXSF | CA | Manufacturing |
|
Adverum Biotechnologies, Inc.
A clinical-stage company developing gene therapies for ocul…
|
ADVM | US | Manufacturing |
|
Advicenne
A specialty pharmaceutical company developing treatments fo…
|
ALDVI | FR | Manufacturing |
|
AegirBio AB
A diagnostics company specializing in therapeutic drug moni…
|
AEGIR | SE | Manufacturing |
|
Aelis Farma
Biopharmaceutical company developing CB1 receptor inhibitor…
|
AELIS | FR | Manufacturing |
|
AEON Biopharma, Inc.
Clinical-stage company developing therapeutic applications …
|
AEON | US | Manufacturing |
|
Aequus Pharmaceuticals Inc.
Developing and commercializing specialty pharmaceutical pro…
|
AQS | CA | Manufacturing |
IO Biotech, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34883/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34883 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34883 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34883 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34883}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IO Biotech, Inc. (id: 34883)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.